• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 13B; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXMC13
Device Problems Device Appears to Trigger Rejection (1524); Patient Device Interaction Problem (4001)
Patient Problem Dysphagia/ Odynophagia (1815)
Event Date 12/06/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information was obtained: trx_2018_01: (b)(6), university of (b)(6), sex: male, age (at time of consent): (b)(6), model: lxmc13, device lot number: 26159, date of surgery: (b)(6) 2021, adverse event term: removal of linx device related to persistent dysphagia and excessive magnetic response between beads of linx device.Severity: severe.Is the adverse event serious? yes.Required in-patient hospitalization or prolongation of existing.Hospitalization: yes.Admission date: (b)(6) 2021.Discharge date: (b)(6) 2021, relationship to study device: probable.Intervention/treatment: none: yes, dilation performed: yes, indicate type of dilation? mechanical, date of dilation: (b)(6) 2021, diagnostic intervention: yes, diagnostic imaging: yes, drug therapy: yes, observation: yes, linx explant: yes, outcome: recovered/resolved.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? no.Yes, additional information was requested, and the following was obtained: what was the date of the explant? (b)(6) 2021.What does ¿excessive magnetic response between beads¿ mean? during an endoflip procedure performed, there was a pressure observed that would not release at the region of the linx device, consistent with the patient's dysphagia symptoms.What affect did the ¿¿excessive magnetic response between beads¿ have on the patient? despite dilation the patient experienced prolonged and severe dysphagia.The patient has been unable to tolerate solid foods, essentially since his initial post-surgical follow-up visit.How was the ¿¿excessive magnetic response between beads¿ determined? while it is only a determination based on observation via endoflip procedure, it appeared that the cause of the patient's dysphagia symptoms was a result of pressure presumably from the linx device.It appeared that the magnetic force between each bead would not release, hence constant pressure observed during endoflip if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported via clinical trial patient experienced removal of linx device related to persistent dysphagia and excessive magnetic response between beads of linx device.Relationship to study device: probable.
 
Manufacturer Narrative
(b)(4).Date sent: 1/27/2022.Investigation summary.An analysis of the product could not be performed since a physical sample was not received for evaluation.As part of ethicon's quality process, all devices are manufactured, inspected, and distributed to approved specifications.If the product is received at a later date, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device batch number 26159, and no non-conformances were identified.
 
Manufacturer Narrative
(b)(4).Date sent: 2/1/2022.Additional information received: from my notes it appears that the subject was dilated during their admission from on (b)(6) 2021 then the explant occurred during the admission from on (b)(6) 2021.Per source, on (b)(6), patient underwent diagnostic laparoscopy, removal of intra-abdominal foreign body, esophagogastroduodenoscopy with dilation.Dense adhesions around the lynx beads.Lynx beads removed.
 
Manufacturer Narrative
(b)(4).Date sent: 3/24/2022.Additional information received: (b)(6) log line: 4 adverse event term: right arm pain at former iv site, relationship to study device: not related, relationship to primary study procedure: not related.Adverse event for (b)(6) log line: 1 resulted in medical or surgical intervention to prevent life-threatening illness or injury or permanent impairment to a body structure or a body function : no : yes.Relationship to study device : probable : causal relationship.Adverse event for (b)(6) log line: 5, indicate type of dilation? pneumatic, date of dilation: (b)(6) 2021.Adverse event for (b)(6) log line: 3 adverse event term: pain with swallowing food, relationship to study device: possible, relationship to primary study procedure: unlikely, drug therapy: yes.
 
Manufacturer Narrative
(b)(4).Date sent: 5/6/2022.Additional information provided: required in-patient hospitalization or prolongation of existing hospitalization: yes.Admission date: on (b)(6) 2021.Discharge date: on (b)(6) 2021.Relationship to study device: possible.Relationship to primary study procedure: not related.Diagnostic imaging: yes.Drug therapy: yes.Observation: yes.Laparoscopic procedure removal: yes.Adverse event term: right arm pain at former iv site.Relationship to study device: not related.Relationship to primary study procedure: not related.
 
Manufacturer Narrative
(b)(4).Date sent; 6/8/2022.Additional information received: if event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : n/a, yes.
 
Manufacturer Narrative
(b)(4).Date sent: 6/20/2022.Additional information received: what does ¿excessive magnetic response between beads¿ mean? immediately after the implant on postop day 0 of the night of surgery and postop day 1 the patient experienced severe dysphagia to solid food.In my experience this is exceedingly abnormal as usually we do not develop deficits dysphagia in total 10 to 14 days postoperatively.Her imaging revealed that the beads were in the correct position.1 hypothesis is that the were or if magnets that were used to manufacture this particular linx implant were higher than normal magnetic field and therefore created the dysphagia.How was the ¿¿excessive magnetic response between beads¿ determined? excessive magnetic response between beads was not determined.It was hypothesized as 1 possible etiology of the severe dysphagia that occurred immediately postop.To determine whether or not there was excessive magnetic force between the beads i have explant of the lynx implant and sent a pack to ethicon for evaluation to see if there is excessive magnetic force beyond the manufacturer specifications.Additional comments from medical safety officer: while it can be mentioned in the narrative as such, the surgeon¿s ¿hypothesis¿ should not be considered a pec or ac.It¿s just a guess.
 
Manufacturer Narrative
(b)(4); date sent: 8/11/2022.Additional information received: if event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : yes -n/a.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : blank - n/a.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : yes -blank.
 
Manufacturer Narrative
(b)(4).Date sent: 10/12/2023 additional information provided: if yes, choose the primary ae log line, start date and term: : #002 (b)(6) 2021-dysphagia => #001 (b)(6) 2021-dysphagia.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 13B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4545 creek road
cincinnati OH
Manufacturer Contact
kara ditty-bovard
4188 lexington avenue north
shoreview 55126
6107428552
MDR Report Key13078165
MDR Text Key287417764
Report Number3008766073-2021-00266
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005332
UDI-Public00855106005332
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/27/2023
Device Model NumberLXMC13
Device Catalogue NumberLXMC13
Device Lot Number26159
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/09/2021
Initial Date FDA Received12/23/2021
Supplement Dates Manufacturer Received01/27/2022
02/01/2022
03/14/2022
04/28/2022
05/31/2022
06/16/2022
08/10/2022
10/04/2023
Supplement Dates FDA Received01/27/2022
02/01/2022
03/24/2022
05/07/2022
06/08/2022
06/20/2022
08/11/2022
10/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/27/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age35 YR
Patient SexMale
-
-